Characterizing the blood stage antimalarial activity of pyronaridine in healthy volunteers experimentally infected with Plasmodium falciparum
Bridget E. Barber, Rebecca Webster, Adam J. Potter, Stacey Llewellyn, Nischal Sahai, Indika Leelasena, Susan Mathison, Karsten Kuritz, Julia Flynn, Stephan Chalon, Anne Claire Marrast, Nathalie Gobeau, Joerg J. Moehrle
doi: https://doi.org/10.1101/2023.09.13.23295466
Bridget E. Barber
1QIMR Berghofer Medical Research Institute, Brisbane, Australia
2University of the Sunshine Coast, Morayfield, Australia
5Royal Brisbane and Women’s Hospital, Brisbane, Australia
Rebecca Webster
1QIMR Berghofer Medical Research Institute, Brisbane, Australia
Adam J. Potter
1QIMR Berghofer Medical Research Institute, Brisbane, Australia
Stacey Llewellyn
1QIMR Berghofer Medical Research Institute, Brisbane, Australia
Nischal Sahai
2University of the Sunshine Coast, Morayfield, Australia
Indika Leelasena
2University of the Sunshine Coast, Morayfield, Australia
Susan Mathison
2University of the Sunshine Coast, Morayfield, Australia
Karsten Kuritz
3IntiQuan GmbH, Basel, Switzerland
Julia Flynn
4Medicines for Malaria Venture, Geneva, Switzerland
Stephan Chalon
4Medicines for Malaria Venture, Geneva, Switzerland
Anne Claire Marrast
4Medicines for Malaria Venture, Geneva, Switzerland
Nathalie Gobeau
4Medicines for Malaria Venture, Geneva, Switzerland
Joerg J. Moehrle
4Medicines for Malaria Venture, Geneva, Switzerland
Article usage
Posted September 15, 2023.
Characterizing the blood stage antimalarial activity of pyronaridine in healthy volunteers experimentally infected with Plasmodium falciparum
Bridget E. Barber, Rebecca Webster, Adam J. Potter, Stacey Llewellyn, Nischal Sahai, Indika Leelasena, Susan Mathison, Karsten Kuritz, Julia Flynn, Stephan Chalon, Anne Claire Marrast, Nathalie Gobeau, Joerg J. Moehrle
medRxiv 2023.09.13.23295466; doi: https://doi.org/10.1101/2023.09.13.23295466
Characterizing the blood stage antimalarial activity of pyronaridine in healthy volunteers experimentally infected with Plasmodium falciparum
Bridget E. Barber, Rebecca Webster, Adam J. Potter, Stacey Llewellyn, Nischal Sahai, Indika Leelasena, Susan Mathison, Karsten Kuritz, Julia Flynn, Stephan Chalon, Anne Claire Marrast, Nathalie Gobeau, Joerg J. Moehrle
medRxiv 2023.09.13.23295466; doi: https://doi.org/10.1101/2023.09.13.23295466
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2923)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12723)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4571)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2913)
- Health Policy (1069)
- Hematology (387)
- HIV/AIDS (924)
- Medical Education (423)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4341)
- Nursing (235)
- Nutrition (637)
- Oncology (2264)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (500)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6925)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (486)
- Toxicology (60)
- Transplantation (210)
- Urology (179)